Online inquiry

IVTScrip™ mRNA-Human ARRDC1-AS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26878MR)

This product GTTS-WK26878MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARRDC1-AS1 protein. This product can be used in Ciliated epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 85026
UniProt ID Q9H2J1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRDC1-AS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26878MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK26892MR IVTScrip™ mRNA-Human ASAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASAP2
GTTS-WK13103MR IVTScrip™ mRNA-Human ADAMTS4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS4
GTTS-WK25404MR IVTScrip™ mRNA-Human ASCC3, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ASCC3
GTTS-WK27533MR IVTScrip™ mRNA-Human ASXL3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASXL3
GTTS-WK23242MR IVTScrip™ mRNA-Human ARL4C, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL4C
GTTS-WK10139MR IVTScrip™ mRNA-Human ADGRE5, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADGRE5
GTTS-WK2853MR IVTScrip™ mRNA-Human MCAM, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA MCAM
GTTS-WK18736MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA alpha-Sarcoglycan
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW